NUVL.D

Nuvalent, Inc.

Healthcare · Biotechnology

$71.63 sample

+0.69 (+0.97%) 1D

Market cap

$92.6B

Price as of

2026-10-24

Latest filing

8-K · 2026-09-11

Alerts

8

Price$71.63 +16.62% 3M daily closessample

71.6359.79

2026-07-282026-08-192026-09-102026-10-012026-10-23

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 19INSInsider buy: 10% owner
Oct 09INSInsider sell: Director
Oct 02INSInsider sell: 10% owner
Sep 24INSInsider sell: Director
Sep 17INSInsider buy: EVP, Operations
Sep 11SECDEF 14A filed
Sep 08INSInsider sell: Director
Sep 02INSInsider sell: 10% owner

Sign up to see the real NUVL.D record →

Company facts

SEC EDGAR registration

Name: Nuvalent, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +22sample, -100 to +100
Reporting currency: USD

Who is positioning in NUVL.D

sample

Insiders: 10 insider transactions over 90 days, net selling, $749.5M
Congress: 5 members traded over 90 days
Institutions · 13F: 10 funds hold $2.0B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$2.9B +10.1% y/y

Q4 2024Q3 2026

Inventory$1.8B +14.2% y/y

Q4 2024Q3 2026

Accounts receivable$1.4B +19.9% y/y

Q4 2024Q3 2026

Total debt$3.6B +10.6% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $15.7B +3.5% 3M
Sample peer B: $86.1B -10.1% 3M
Sample peer C: $29.5B -3.5% 3M
Sample peer D: $52.8B -7.1% 3M
Sample peer E: $50.9B +9.2% 3M